microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection—A Commentary
Open Access
- 18 June 2021
- journal article
- editorial
- Published by MDPI AG in Non-Coding RNA
- Vol. 7 (2), 37
- https://doi.org/10.3390/ncrna7020037
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the genus Betacoronavirus in the family Coronaviridae, possesses an unusually large single-stranded viral RNA (ssvRNA) genome of about ~29,811 nucleotides (nt) that causes severe and acute respiratory distress and a highly lethal viral pneumonia known as COVID-19. COVID-19 also presents with multiple ancillary systemic diseases and often involves cardiovascular, inflammatory, and/or neurological complications. Pathological viral genomes consisting of ssvRNA, like cellular messenger RNA (mRNA), are susceptible to attack, destruction, neutralization, and/or modulation by naturally occurring small non-coding RNAs (sncRNAs) within the host cell, some of which are known as microRNAs (miRNAs). This paper proposes that the actions of the 2650 known human miRNAs and other sncRNAs form the basis for an under-recognized and unappreciated innate-immune regulator of ssvRNA viral genome activities and have implications for the efficiency of SARS-CoV-2 invasion, infection, and replication. Recent research indicates that both miRNA and mRNA abundance, speciation, and complexity varies widely amongst human individuals, and this may: (i) In part explain the variability in the innate-immune immunological and pathophysiological response of different human individuals to the initiation and progression of SARS-CoV-2 infection in multiple tissue types; and (ii) further support our understanding of human biochemical and genetic individuality and the variable resistance of individuals to ssvRNA-mediated viral infection and disease. This commentary will briefly address current findings and concepts in this fascinating research area of non-coding RNA and innate-immunity with special reference to natural host miRNAs, SARS-CoV-2, and the current COVID-19 pandemic.Keywords
Funding Information
- National Institutes of Health (NEI EY006311, NIA AG18031, NIA AG038834)
This publication has 46 references indexed in Scilit:
- A Broad RNA Virus Survey Reveals Both miRNA Dependence and Functional SequestrationCell Host & Microbe, 2016
- Coronaviruses: An Overview of Their Replication and PathogenesisPublished by Springer Science and Business Media LLC ,2015
- Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic virusesFrontiers in Microbiology, 2015
- Analysis of RNA from Alzheimer’s Disease Post-mortem Brain TissuesMolecular Neurobiology, 2015
- Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD)Frontiers in Cellular Neuroscience, 2013
- Mammalian microRNAs predominantly act to decrease target mRNA levelsNature, 2010
- A structural understanding of the dynamic ribosome machineNature Reviews Molecular Cell Biology, 2008
- Antiviral Immunity Directed by Small RNAsCell, 2007
- Hypersusceptibility to Vesicular Stomatitis Virus Infection in Dicer1-Deficient Mice Is Due to Impaired miR24 and miR93 ExpressionImmunity, 2007
- Gene expression profiling of adipose tissue:: individual, depot-dependent, and sex-dependent variabilitiesNutrition, 2004